ReviewCureus2026

Insulin Deintensification After Glucagon-Like Peptide-1 (GLP-1)-Based Therapy in Type 2 Diabetes: Evidence and a Practical Clinical Framework.

Ahmed Elhassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.